CRL : Analysis & Opinions

  1. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  2. BASi Introduces Culex NxT - Analyst Blog

    January 3, 2013
    Following the success of the Culex Automated in vivo sampling system, recently, pharmaceutical development company, Bioanalytical ...
  3. Vertex Pharmaceuticals and Other Healthcare Stocks Making Big ...

    December 24, 2012
    The market has been slipping so far today. The Nasdaq has declined 0.2%; the S&P 500 is trading down 0.3%; and the Dow has ...
  4. Regeneron Pharmaceuticals and More Big Movers in Healthcare on ...

    December 13, 2012
    The Nasdaq has decreased 0.4%, the S&P 500 has fallen 0.3% and the Dow is down 0.2% on a bad morning for the market. The ...
  5. Cobalt International Energy and More Big Movers on the NYSE on ...

    December 12, 2012
    The Nasdaq has been relatively flat, the S&P 500 has climbed 0.2% and the Dow is up 0.2% this morning. The NYSE is a stock ...
  6. The Long-Term Play In Lab Work

    January 16, 2012
    As drugmakers beef up their pipelines in this world of rising costs, the contract research sector should profit.
  7. PPD Goes Private

    October 6, 2011
    PPD's acceptance of a low buyout bid raises questions about the CRO industry.
  8. Four Small Caps From The Perkins Portfolio

    November 4, 2010
    Perkins' small-cap value fund's three- and five-year performance is excellent, and investors should take note.
  9. The Future of Stem Cells

    June 15, 2010
    Stem cells get a lot of attention, but maybe not in the one area where they could prove most effective.
  10. Contract Biotech Is Booming (MDZ, CRL, CVD)

    October 1, 2007
    We examine three companies that the big drug makers call on when they need a little testing done.
Investing News
  1. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  2. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  3. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  4. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  5. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
  6. Can Paying Off Your Mortgage Early Hurt Your Net Worth?

    Saving your money and making double or even triple payments on a mortgage may sound productive, ...
Trading Center